ACHE and early-onset autosomal dominant Alzheimer disease: The acetylcholinesterase enzyme (AChE) is the key enzyme in the hydrolysis of the neurotransmitter acetylcholine and is the target of most of the clinically used drugs for the treatment of Alzheimer’s disease [118].